INVA Q2 2022 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$108M+7.4% YoY

Gross Profit

$108M100.0% margin

Operating Income

$83M76.3% margin

Net Income

$939,0000.9% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+20.2%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$79M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$572M

Stockholders' Equity

$388M

Cash & Equivalents

$284M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$108M	$101M	+7.4%
Gross Profit	$108M	$101M	+7.4%
Operating Income	$83M	$97M	-14.5%
Net Income	$939,000	$89M	-98.9%

Revenue Segments

Royalty

$43M100%